NEWS


News & events

Our seminars

This is the calendar invitation to announce our speaker (details below) and share the “save-the-date”.

​** 21/05/2026 - h. 14:00

speaker: Eleonora Leucci, Laboratory for RNA Cancer Biology, KU Leuven, Belgium
title: Contribution of lncRNAs to the generation of drug-tolerant cells
host: IEO-Bonaldi
location: IFOM Conference Room **

https://gbiomed.kuleuven.be/english/research/50488876/54502087



Contribution of lncRNAs to the generation of drug-tolerant cells
Eleonora Leucci1,*,
1Laboratory for RNA Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium. 2Trace, Leuven Cancer Institute, KU Leuven, Leuven, Belgium
eleonora.leucci@kuleuven.be

Long non-coding RNAs (lncRNAs) generated from remote areas of the human genome constitute a major source of innovation for the adaptation to the numerous stresses encountered by cancer cells during progression and therapy resistance. As such, research in this field offers a unique opportunity to study cancer evolution and unveil novel biology. Over the years, we have characterised several novel transcripts affecting the generation of drug-tolerant cells. These transcripts represent previously unexplored cancer-specific vulnerabilities and thus extend the palette of therapeutic opportunities to include RNA-based medicines.

Contribution of lncRNAs to the generation of drug-tolerant cells

May 21, 2026 14:00

our last paper

Correction: Position statement from the Italian Society of Human Genetics (SIGU) on the implementation of germline pharmacogenetic testing.

Correction: Position statement from the Italian Society of Human Genetics (SIGU) on the implementation of germline pharmacogenetic testing.

Floris M, Moschella A, Capasso M, Alcalay M, Iascone MR, Grammatico P, Gasparini P, Miozzo MR; Italian Society of Human Genetics (SIGU) Working Group on Pharmacogenomics
May , 2026

highlight

Inspirational career development talk by Dr. Eleonora Leucci

Inspirational career development talk by Dr. Eleonora Leucci

highlight

Spring PhD applications are now open!

Spring PhD applications are now open!

highlight

The EU-LIFE Postdoctoral Exchange Programme

The EU-LIFE Postdoctoral Exchange Programme

Our SCIENCE


Research & technology

Our science
Principal Investigators
Technological Units
Translational Research Programs
Technology Transfer Office (IEO-TT)

Our MENTORING


Education & training

Our mentoring
Undergraduate Students
PhD Students
Postdoctoral Fellows
Technicians

Our ALLIANCES


Partners & Networks

JOIN us


Explore our open positions

AVVISO PROCEDURA DI SELEZIONE PER L’ASSEGNAZIONE DI UNA BORSA DI RICERCA (Ref.2026-04-NM/20)

Fellow - Nico Mitro's lab

Reference 2026-04-NM/20

READ MORE
Postdoctoral position for Computational Biologist (Ref. 2026-05-LN/22)

Postdoctoral position for Computational Biologist - Luigi Nezi's lab

Reference 2026-05-LN/22

READ MORE
Technician Position - Laboratory of Oncohematology  (Ref. 2026-05-ED/23)

Technician Position - Laboratory of Oncohematology - Derenzini's lab

Reference 2026-05-ED/23

READ MORE
BANDO DI ASSEGNAZIONE PER UN POSTO DI RICERCATORE POSTDOC CON  CONTRATTO DI COLLABORAZIONE COORDINATA E CONTINUATIVA (Ref. 2026-05-NF_LM/24)

Postdoc - Luca Mazzarella's lab

Reference. 2026-05-NF_LM/24

READ MORE

Over the past 30 years since DEO’s founding, numerous scientists have launched and advanced their careers here. This has created a broad community of researchers who, despite being spread across institutes worldwide, still cherish their experiences at IEO and maintain strong ties to the department. In 2018, DEO held its inaugural Alumni meeting, bringing together 50 former PhD students, postdocs, and Group Leaders, now Principal Investigators or Institute Directors internationally, to reconnect and engage in scientific discussions.

READ
Iliyan D. Lliev

Iliyan D. Lliev

IEO PhD student 2005‑2009

VIEW DETAILS

SUPPORT us


In Italy, taxpayers have the option to donate 0.5% of their taxes to non-profit organizations through the “Cinque per mille” (5x1000) scheme.

When submitting your income tax return via the 730 or CUD forms, you can designate 5x1000 of your tax to the European Institute of Oncology (IEO), helping to advance research, innovation, and treatment.

Clinical activities at IEO are conducted at the IEO Hospital on Via Ripamonti.
IEO’s core values focus on prioritizing patients’ needs and pursuing ongoing self-improvement to achieve excellence in clinical care and research, all within a multidisciplinary framework